Across an increasing number of studies, kisspeptin has been shown to restore reproductive hormone secretion in men and women with hypogonadism (such as HA, hyperprolactinaemia and diabetes‐induced hypogonadism), as well as safely induce egg maturation in women undergoing IVF. This evidence concerns the gene KISS1 and hypogonadism.